Category: Implant Biology

• What Happens Immediately After Extraction?

• How Does New Bone Form Inside the Socket?

• Why Does the Ridge Still Shrink?
• What Changes During the First Eight Weeks?

• Why This Matters for Implant Planning

When a tooth is extracted, what remains is not simply an empty extraction socket waiting to be filled with new bone. At that moment, one of the most dynamic remodeling processes in oral surgery begins, and what is particularly important is that two processes that initially appear contradictory occur simultaneously: the body forms new bone within the socket while at the same time resorbing part of the bony walls that originally formed that socket. This is why, eight weeks after extraction, the socket may be largely filled with newly formed bone while the alveolar ridge is nevertheless narrower and lower than it was on the day of extraction. This paradox is fundamental to understanding extraction wound healing. Immediately after extraction, the socket fills with blood and a blood clot forms. The clot is not merely a plug that stops bleeding, but a temporary biologic scaffold on which the organization of future tissue begins. The fibrin network contains erythrocytes and platelets, and inflammatory cells begin to enter the wound area as early as the first day. This is not a complication, but part of normal healing. The body must clear the damaged area while simultaneously preparing the site for new vascularization and regeneration. By approximately the third day, the marginal portions of the blood clot begin to be replaced by highly vascularized connective tissue. In other words, what looked like a clot the day before begins to transform into living tissue permeated by new blood vessels. The central and apical portions of the socket still lag behind this process, demonstrating that healing is not uniform and that different parts of the same extraction wound may be in different biologic phases at the same time. By approximately the seventh day, the change becomes even more dramatic. The blood clot and granulation tissue become organized through neovascularization, undifferentiated mesenchymal cells, leukocytes, and collagen fibers growing inward from the periphery. The socket is no longer a passive cavity. It becomes an intensely active construction site. Blood vessels are particularly important because reliable bone regeneration cannot occur without angiogenesis. They not only deliver oxygen and nutrients but also create the biologic environment in which osteoprogenitor cells can differentiate into osteoblasts. At the same time, osteoclast activity also increases. This is a detail that is often overlooked: bone healing does not mean bone formation alone. Regeneration involves precisely coordinated resorption of existing structures and formation of new ones. By the second week, the marginal portion of the socket begins to acquire an epithelial covering, while the highly vascularized mesenchymal component increasingly occupies the space previously filled by the blood clot. Remnants of the periodontal ligament and the alveolar bone plate undergo degradation, creating communications with the bone marrow of the surrounding cancellous bone. It is through this vascular and cellular network that a more substantial phase of osteogenesis begins. Woven bone appears in the central portions of the socket. It forms rapidly, but it is not yet the mature lamellar bone we want to see as the final result of healing. Woven bone represents a temporary structure that the body will later remodel and replace with a more organized lamellar structure. By approximately the thirtieth day, the wound surface may already appear surprisingly calm. The marginal portion is covered by organized connective tissue and keratinized stratified squamous epithelium. Beneath the surface, however, remodeling remains highly active. The first primary osteons appear within the newly formed woven bone, marking the beginning of its maturation, while numerous osteoclasts participate in the remodeling of both newly formed and preexisting bone. In other words, one month after extraction, the bone has not finished healing; it is only beginning to undergo intensive changes in its internal architecture. At the same time, a process that may be even more important to the implant dentist than the filling of the socket itself begins to become apparent: a change in the external dimensions of the ridge. The alveolar ridge exists because the tooth exists. After the tooth is removed, part of the bony anatomy loses its original biologic and functional role, and the body begins to remodel it. Resorption occurs on both the buccal and oral aspects, but it is not symmetrical. The buccal bone plate is particularly susceptible to change, and more pronounced horizontal and vertical losses may therefore develop on this side. By approximately the fifth week, narrowing of the ridge and flattening of the buccal bone plate may already be clearly evident. This is clinically extremely important because the patient may have a completely closed wound and the impression that the area has healed, while beneath the mucosa the geometry of the ridge has already changed substantially. By the eighth week, the extraction socket may be largely filled with woven bone, but this in no way means that the anatomy has returned to its pre-extraction condition. On the contrary, very pronounced dimensional changes may occur during this early period, particularly on the buccal aspect. Experimental models show that osteoclast activity during this period may lead to substantial resorption of the crestal portions of the buccal and lingual walls, with more pronounced changes on the buccal side. Even more strikingly, after eight weeks the sockets may be filled with woven bone while vertical buccal bone loss simultaneously amounts to several millimeters. The body heals the wound very successfully, but it has no biologic reason to preserve the identical external architecture of the bone that existed while the tooth was present. This is why atraumatic extraction makes sense, but even a perfectly performed extraction cannot, by itself, completely prevent physiologic remodeling. Likewise, immediate implant placement does not provide magical protection against resorption of the buccal bone plate. After extraction, biology continues its remodeling program regardless of our prosthetic plans. The most important message of the first eight weeks, therefore, is not how quickly the space left by the extracted tooth fills with bone, but what kind of ridge will remain once the most intensive early phase of remodeling has ended. In just a few weeks, the blood clot becomes a vascularized matrix, the matrix becomes woven bone, maturation begins, the surface becomes epithelialized, and at the same time the external contour of the ridge decreases. This is why, in contemporary implant dentistry, tooth extraction should not be viewed as the end of one treatment. It is the beginning of a biologic process that will determine the anatomy of the future implant site.

• What Is the Supracrestal Tissue Attachment?

• How Much Vertical Space Is Required?

• What Happens When Space Is Insufficient?

• Clinical Implications for Implant Placement

An implant may be perfectly osseointegrated, the prosthetic restoration may look excellent, and yet a process may still begin around its neck that alters the level of the marginal bone. The reason is simple: the soft tissue around an implant must form its own protective biologic attachment, and it needs space to do so. If there is not enough space, the body cannot simply bypass this requirement. It will attempt to create that space, and the crestal bone often pays the price. Biologic width represents the vertical zone between the most coronal portion of the epithelial attachment and the alveolar bone. Around an implant, this zone consists of approximately one millimeter of epithelial attachment and approximately one millimeter of supracrestal connective tissue, with the peri-implant sulcus located above them. When the entire soft-tissue complex is considered, approximately three millimeters of supracrestal space is required for the tissues to organize into a stable barrier. This is not an arbitrary measurement, but a consequence of the way the epithelium and connective tissue establish a boundary between the oral environment and the deeper peri-implant structures. The problem begins when the implant or its components are positioned in such a way that insufficient space remains for this barrier. The body cannot compress the required structures simply because we have placed the implant at a certain depth. Instead, remodeling of the crestal bone may begin. The bone shifts apically until sufficient space is created for the epithelial and connective-tissue components to assume a more stable position. This is why early marginal bone loss around an implant does not automatically indicate peri-implantitis. Under certain circumstances, it may represent a biologic adaptation through which the body reestablishes the required supracrestal tissue dimension. This is precisely where an important diagnostic pitfall arises: radiographic bone loss is not synonymous with inflammatory disease. Peri-implantitis involves much more than the simple fact that the bone level is lower than it was previously. Inflammation of the peri-implant mucosa, probing findings, the course of the changes, and progression of supporting bone loss must all be analyzed. Biologic width around an implant is also not completely identical to that around a natural tooth. Around a natural tooth, collagen fibers of the periodontal complex can insert into the cementum, whereas an implant has neither cementum nor a periodontal ligament. The connective-tissue fibers adjacent to an implant are organized differently and do not form the same insertion system that exists around the root of a natural tooth. For this reason, soft-tissue contact with an implant represents a distinct biologic structure. The junctional epithelium can establish an attachment to the implant surface through the basal lamina and hemidesmosomes, but this is not the same as fibrous attachment to the cementum of a natural tooth. The stability of the supracrestal soft tissue is therefore extremely important for protecting the deeper peri-implant region. Experimental studies have shown that adequate supracrestal space is necessary for stable organization of this complex and that, when this space is insufficient, crestal bone resorption may be expected. In other words, the bone may recede until the soft tissue acquires the space it requires. This leads to one of the most important messages in implant dentistry: the body will remodel the marginal bone rather than abandon the formation of a physiologic soft-tissue barrier. However, the problem does not end there. When the bone recedes, a portion of the implant surface that was previously surrounded by bone may become supracrestal. If that surface is rough and difficult to access for oral hygiene, this may facilitate biofilm retention. Thus, adaptive remodeling that is not itself peri-implantitis may create an anatomic situation that is more favorable for future inflammation. This is precisely why the position of the implant–abutment connection, the height of the peri-implant soft tissue, the design of the implant neck, and the vertical position of the platform are not insignificant technical details. They determine the space within which the body will attempt to build its protective soft-tissue complex. Histologic findings demonstrate how pronounced this adaptation may be: when the initial biologic width is insufficient, the crestal bone may resorb, sometimes producing a characteristic funnel-shaped change around the implant neck. It is also important to recognize that, once formed, the soft-tissue barrier is not a structure that can be manipulated indefinitely without consequences. Removing and reconnecting the abutment may disrupt the existing attachment and require the tissues to reorganize. For this reason, every intervention in this region should have a clear rationale rather than being performed as a routine habit. Additional attention has been drawn to the concept of platform switching, in which the implant–abutment connection is shifted horizontally toward the center of the implant platform. The idea is to move the inflammatory zone associated with the connection away from the marginal bone while simultaneously providing a different spatial organization of the soft tissues. Nevertheless, no design can override fundamental biology if the implant is placed in an unfavorable three-dimensional position. Implant placement depth is therefore not merely a prosthetic or esthetic issue. A component placed too deeply may alter the relationship between the soft tissue and bone, whereas a position that is too superficial may create entirely different esthetic and functional problems. In the esthetic zone, the consequences are particularly important because changes in the marginal bone may alter the mucosal contour and papilla position. A sound implant treatment plan therefore does not end with the question of where there is sufficient bone to place the implant. It must also address where the bone will be located after healing, where the connective tissue will terminate, where the epithelial attachment will be positioned, and at what level the prosthetic connection will lie. When you examine the marginal bone around an implant on a radiograph, you are actually looking at one of the boundaries of an active biologic system that is constantly attempting to establish equilibrium among bone, soft tissue, the implant surface, and the oral environment. If you provide this system with adequate space, it has a chance to stabilize. If you deprive it of that space, biology will not accept our plan simply because the implant has been technically well placed. The body will attempt to create the space it requires, and very often it will create that space precisely where we least want to lose it—at the expense of the crestal peri-implant bone.

Imagine two almost identical smiles. One contains a natural tooth; the other, an implant with a crown that perfectly mimics it. The patient may not perceive any difference, but biologically, the difference is substantial. An implant can replace a missing tooth extremely successfully in both functional and esthetic terms, but it cannot completely reconstruct the tooth’s natural supporting apparatus. This is where the explanation begins as to why the tissues around an implant may be more vulnerable to the long-term presence of bacterial biofilm. A natural tooth is not simply a piece of hard tissue embedded in bone. Between the root and the alveolar bone lies the periodontal ligament, a complex, highly vascularized and innervated tissue rich in cells with significant regenerative potential. Its collagen fibers insert into the root cementum at one end and into the alveolar bone at the other, creating a true biologic attachment system. An implant functions in an entirely different way. In successful osseointegration, its surface establishes direct contact with bone, but no periodontal ligament forms around it. Osseointegration is one of the greatest achievements of modern implant dentistry, but at the same time, it means that an implant lacks one of the important anatomic structures present around a natural tooth. The difference becomes even more interesting when we examine the soft tissue. Around a natural tooth, there are complex supracrestal bundles of collagen fibers, including fibers that establish a firm attachment to the cementum. The periodontal ligament is also richly vascularized and contains fibroblasts, cementoblasts, osteoblasts, osteoclasts, and other cellular elements involved in remodeling and regeneration. No such apparatus exists around an implant. Instead, between the apical end of the junctional epithelium and the crestal bone lies a zone of connective tissue whose inner portion may be dense, relatively poorly vascularized, and organized in a manner resembling scar tissue. In many experimental descriptions, the collagen fibers are predominantly oriented parallel or circumferentially to the implant, although the literature also describes other patterns of fiber orientation. Around a natural tooth, fibers that attach to the cementum create a complex connective-tissue architecture, whereas around an implant there is no cementum into which the same periodontal fiber system could insert. In other words, the soft tissue around an implant forms a biologic barrier, but it is not a complete replica of the periodontal apparatus of a natural tooth. Nevertheless, an implant is not completely unprotected. Oral epithelium, sulcular epithelium, and junctional epithelium are present around it, and the junctional epithelium can establish an attachment to the implant surface through structures that ultrastructurally resemble the basal lamina and hemidesmosomes of a natural tooth. It is therefore incorrect to say that the body treats an implant as an unprotected piece of metal. The body creates a sophisticated mucosal barrier around it. The problem is that this barrier functions in a different anatomic environment. When biofilm accumulates on the implant surface, bacterial products come into contact with tissues that initiate an innate immune response. In an early peri-implant mucositis lesion, the numbers of neutrophils, macrophages, and T lymphocytes increase, vascular permeability increases, and loss of collagen structures begins in the subepithelial connective tissue. If the biofilm is not controlled, the inflammatory infiltrate becomes denser and extends laterally and apically. B lymphocytes and plasma cells appear, while inflammatory mediators promote further fibroblast damage, collagen loss, and the development of conditions that can activate osteoclastic mechanisms. Between the inflammatory process and the crestal bone around the implant, only a relatively thin layer of noninfiltrated connective tissue may remain. This means that persistent inflammation around an implant should not be viewed as a harmless version of gingivitis around a natural tooth. The peri-implant mucosa may appear relatively quiet for a long time while a highly active immune process is taking place at the microscopic level. Another important point is that the junctional epithelium itself is not a passive protective structure. Around a natural tooth, it also forms part of the immune boundary with the oral microbiota, allowing an exchange of bacterial products and components of the host defense system. A similar epithelial component exists around an implant, but beneath it there is no periodontal ligament with its characteristic vascular, cellular, and fibrous apparatus. Therefore, the statement that an implant has “weaker defense” should be understood precisely: an implant is not immunologically helpless, but its peri-implant tissues have a different and, in some respects, less robust anatomic organization than the tissues surrounding a natural tooth. This is why good implant dentistry does not end when the crown is placed and the patient leaves the office. True long-term success begins at that point. Biofilm control, hygienic access to the prosthetic restoration, monitoring of the peri-implant mucosa, and regular follow-up visits are not additions to treatment; they are part of implant biology. An implant may function flawlessly for decades, but we should not expect it to possess all the protective mechanisms of a tooth that evolution developed as an integral part of the periodontal complex of the natural tooth. The most dangerous misconception, therefore, is not that an implant is an artificial tooth. The most dangerous misconception is treating it as though it were biologically identical to a natural tooth.